scholarly journals Impact of pathologic lymph node‐positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer

Cancer ◽  
2020 ◽  
Vol 126 (13) ◽  
pp. 2991-3001 ◽  
Author(s):  
Arnav Srivastava ◽  
Zorimar Rivera‐Núñez ◽  
Sinae Kim ◽  
Joshua Sterling ◽  
Nicholas J. Farber ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Lymph Node ◽  
Cell Carcinoma ◽  
Kidney Cancer ◽  
Renal Cell ◽  
Stage Iv ◽  
Node Positive ◽  
Lymph Node Positive ◽  
Definition Of ◽  
Pathologic Lymph Node

1801 IMPACT OF LYMPH NODE DENSITY ON CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH NODE-POSITIVE RENAL CELL CARCINOMA

2010 ◽  
Vol 183 (4S) ◽  
Author(s):  
Marco Roscigno ◽  
Elena Strada ◽  
Giovanni Petralia ◽  
Francesco Sozzi ◽  
Carlo Terrone ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Lymph Node ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Node Density ◽  
Cancer Specific Survival ◽  
Lymph Node Density ◽  
Node Positive

IMPACT OF LYMPH NODE DENSITY ON CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH NODE-POSITIVE RENAL CELL CARCINOMA

2009 ◽  
Vol 181 (4S) ◽  
pp. 250-250
Author(s):  
Marco Roscigno ◽  
Roberto Bertini ◽  
Elena Strada ◽  
Giovanni Petralia ◽  
Francesco Sozzi ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Lymph Node ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Node Density ◽  
Cancer Specific Survival ◽  
Lymph Node Density ◽  
Node Positive

scholarly journals NCCN Guidelines Insights: Kidney Cancer, Version 1.2021

2020 ◽  
Vol 18 (9) ◽  
pp. 1160-1170 ◽  
Author(s):  
Robert J. Motzer ◽  
Eric Jonasch ◽  
Shawna Boyle ◽  
Maria I. Carlo ◽  
Brandon Manley ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Genetic Testing ◽  
Cell Carcinoma ◽  
Kidney Cancer ◽  
Systemic Therapy ◽  
Renal Cell ◽  
Treatment Options ◽  
Stage Iv ◽  
Diagnostic Workup ◽  
Nccn Guidelines

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to certain systemic therapy recommendations for patients with relapsed or stage IV RCC. They also discuss the addition of a new section to the guidelines that identifies and describes the most common hereditary RCC syndromes and provides recommendations for genetic testing, surveillance, and/or treatment options for patients who are suspected or confirmed to have one of these syndromes.

scholarly journals Precision Surgery and Kidney Cancer: Knowledge of Genetic Alterations Influences Surgical Management

Genes ◽  
2021 ◽  
Vol 12 (2) ◽  
pp. 261 ◽  
Author(s):  
Patrick T. Gomella ◽  
W. Linehan ◽  
Mark W. Ball
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Surgical Management ◽  
Kidney Cancer ◽  
Renal Cell ◽  
Management Strategies ◽  
Genetic Alterations ◽  
Cancer Knowledge ◽  
Biological Potential

Renal cell carcinoma is a term that represents multiple different disease processes, each driven by different genetic alterations, with distinct histology, and biological potential which necessitates divergent management strategies. This review discusses the genetic alterations seen in several forms of hereditary kidney cancer and how that knowledge can dictate when and how to intervene with a focus on the surgical management of these tumors.

Sign in / Sign up

Export Citation Format

Share Document